MedTrace Logo

Cancer Survivorship in Hematologic Malignancies

NCT05780411 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-03-22

No results posted yet for this study

Summary

General objective: to improve care for haematological cancer survivors. This study will (i) Estimate the incidence of cancer survivor syndrome (CSS) in adult Egyptian patients with haematological neoplasms (HN). (ii) Asses the risk factors of CSS in patients with HN. (iii) Study the effect of CSS on quality of life in patients with HN. (iv) To explore coping strategies of patients with HN having CSS

Conditions

  • Cancer Survivors

Interventions

OTHER

questionnaire

The symptom related checklist questionnaire, Quality of life questionnaire, Coping strategies questionnaire, Distress thermometer

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Safaa AA Khaled, MD, PhD · Professor, Department of Internal Medicine, Assiut University

  • Zain E Ahmed, MD, PhD · Professor, Department of Internal Medicine, Assiut University

  • Roaa M Saleh, MD · Resident Doctor, Department of Internal Medicine, Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-01-31
Completion
2025-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05780411 on ClinicalTrials.gov